Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-11-14
2006-11-14
Saunders, David (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S006120, C435S091200, C435S091210
Reexamination Certificate
active
07135302
ABSTRACT:
The present invention relates to a method for predicting whether or not transplant recipients are likely to reject tissue allografts. It is based, at least in part, on the discovery that, based on analysis of three immunologic factors, cardiac transplant recipients could be classified into risk categories for progression to high-grade rejection. The present invention, by enabling a determination of the risk for high-risk rejection in a transplant patient, reduces unnecessary diagnostic and therapeutic procedures in low risk patients and clinical intervention in patients who would most benefit.
REFERENCES:
Itescu et al, Circulation, 98(8), 786-793, 1998.
Lazada, Transplantation, 57(6), 964-969, 1994.
Ten Hoor et al, Transplantation, 56(2), 298-304, 1993.
Hosenpud J.F., Novick R.J., Bennett L.E., Keck B.M., Fiol B., Daily P.O. The Registry of the International Society of Heart and Lung Transplantation 1996; 15:655.
Kormos, R., Arimtage, J., Wolyn, T. et al. Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. The Journal of Heart and Lung Transplantation 1992; 11(3):S104-110.
Kerman, R.H., Kimball, P., Scheinen, S. et al. The relationship among donor-recipient HLA mismatches, rejection, and death from coronary artery disease in cardiac transplant recipients. Transplantation 1994; 57(6); 884-8.
Smith, J.D., Rose, M.L., Pomerance, A., Burke, M., Yacoub, M.H. Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching. Lancet 1995; 346:1318-22.
Costanzo-Nordin, M.R. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility. The Journal of Heart and Lung Transplantation 1992; 11:S90-103.
Suciu-Foca N., Reed E., Marboe C., Xi Y.P., Kai S.Y., Ho E., Rose E.A., Reemstma K., King, D.W. Role of anti-HLA antibodies in heart transplantation. Transplantation 1991; 51:716-724.
Hess M., Hastillo A., Mohanakamar T., Crowley J.J., Vetrovac G., Szentpetery, S., Wolfgang, T.C., Lower R.R.. Accelerated atherosclerosis in cardiac transplantation: role of cytoxic B-cell antibodies and hyperlipidemia. Circulation 1983; 68:94-101.
Rose, E.A., Pepino P., Barr M., Smith C., Ratner A., Ho E., Berger C. Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. The Journal of Heart and Lung Transplantation 1992; S120-123.
DeMattos, A.M. Head M.A., Everett, J., et al. HLA-DR mismatching correlates with early cadiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used. Transplantation 1994; 57(4);626-630.
Kriklin, J.K., Bourge, R.C., BBarr, M.L., et al. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. The cardiac transplant research databae group. The Journal of Heart and Lung Transplantation. 1995; 13(4); 583-95.
Keogh, A., Kaan, A., Doran, T., et al. HLA mismatching and outcome in heart, heart-lung and single lung transplantation. The Journal of Heart and Lung Transplantation. 1995; 14(3);444-51.
Fischer, P.E., Suciu-Foca, N., Ho, E., Tugulea, S., Rose E.A., Michler, R.E., Mancini, D. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy speciments: implications for therapy. Journal of Heart and Lung Transplantation 1995; 14:1156-1161.
Liu, Z., Sun, Y.K., Xi, Y.P., Maffei, A., Harris, P.E., Suciu-Foca, N. Contribution of direct and indirect recognition pathway to T cell alloreactivity. Journal of Experimental Medicine 1993; 177:1643-1650.
Liu, Z., Colovai, A.I., Tugulea, S., Reed, E.F., Fisher, P.E., Mancini, D., Rose, E.A., Cortesini, R., Michler, R.E., Suciu-Foca, N., Indirect Recognition of donor HLA-DR peptides in organ allograft rejection. Journal of Clinical Investigation 1996; 98:1150-1157.
Tugulea, S., Ciubotariu, R., Colovai, A.I., Liu, Z., Itescu, S., Schulman, L., Fisher, P.E., Hardy, M.A., Rose, E.A., Michler, R.E., Cortesini, R., Suciu-Foca, N. New strategies for early diagnosis of heart allograft rejection. Transplantation 1997: 64:842-847.
Ciubotariu, R., Colovai, A.I., Ho, E., Itescu, S., Ravalli, S., Hardy, M.A., Cortesini, R., Rose, E.A., Suciu-Foca, N. Persistant allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. Journal of Clinical Investigation 1998; 101:398-405.
Markus, P.M., Salvaggi, G., Cai, X., Fung, J.J., Starzl, T.E. Induction of donor-specific transplantation tolerance ot skin and cardiac allografts using miched chimerism in (A+B ->A) in rats. Cell Transplantation 1993; 2:345-353.
Zeevi, A., Pavlick, M., Lombardozzi, S., Banas, R., Pappo, O., Rao, A.S., Fontes, P., Demetris, J., Shapiro, R., Dodson, E., et al. Immune status of recipients following bone marrow-augmented solid organ transplantation. Transplantation 1995; 59:616:620.
Creemers, P. Du Toit, E., Cassidy, M.J., Kahn, D. Sequential mixed lymphocyte culture after kidney transplantation: induction of tolerance or sensitization. Nephron 1997; 75: 166-170.
Billingham, M.E. Dilemma of variety of histopathologic grading systems for acute cardiac allograft rejection by endomyocardial biopsy. Journal of Heart Transplantation 1990; 9:272-276.
Kaplan, E.L., and Meier, P. Nonparametric estimation from incomplete observations. Journal of the American Statistic Association 1958; 53: 457-481.
Liang, K.Y., and Zenger, S.L. Longitudinal data analysis using generalized linear models. Biometrica 1986; 73: 13-22.
Krieger, N.R., Yin, D.P., and Fathman, C.G. CD4+ but not CD8+ cells are essential for allorejection. Journal of Experimental Medicine 1996; 84:2013-2018.
Starzl, T.E., Demetris, A.J., Rao, A.S., Thompson, A.M., Trucco, M., Murase, N. Migratory nonparenchymal cells after organ allotransplantation: with particular reference to chimerism and the liver. Progress in Liver Diseases 1994; 12:191-213.
Schlitt, H.J., Hundrieser, J., Hisanaga, M., Uthoff, K., Karck, M., Wahlers, T., Wonigeit, K., Pichlmayr, R. Patterns of donor type microchimerism after heart transplantation. Lancet 1994; 343:1469-1471.
Hisanaga, M., Hundrieser, J., Boker, K., Uthoff, K., Raddaatz, G., Wahlers, T., Winigeit, K., Pichlmayr, R., Schlitt, H.J. Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation 1996: 61:40-45.
Vanderlugt, C.J. and Miller, S.D., Epitope spreading. Current Opinion in Immunology 1996; 8:831-836.
Mamula, M.J. and Janeway, C.A. Jr. Do B cells drive the diversification of immune responses? Immunology Today 1993; 14:151-154.
Reed, E.F., Hong, B., Ho, E., Harris, P.E., Weinberger, J., Suciu-Foca, N. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant associated coronary artery disease. Transplantation 1996; (61)566-72.
Itescu, S., Weinberg, A., Burke, E.M., Tung, T., Oz, M., Reed, E., Suciu-Foca, N., Rose, E.A., Michler, P.E. Influence of pre-formed IgG anti-HLA antibodies on development of cellular rejection in highly sensitized cardiac allograft recipients. The Journal of Heart and Lung Transplantation 1997: 16(1): 78.
Lavee, J., Kormos, R.L., Duquesnoy, R.J., Zerbe, T.R., Armitage, J.M., Vaneck, B.S., Hardesty, R.L., and Griffith, B.P. Influence of panel-reactive antibody and lymphocytotoxic crossmatch on survival after heart transplantation. Journal of Heart and Lung Transplantation 1991; 6:921-930.
Loh, E., Bergin, J.D., Couper, G.S., Mudge, G.H. Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation. Journal of Heart and Lung Transplantation 1994; 13:194-201.
Valentine, H.A., Yeoh, T.K., Gibbons, R., McCarthy, P., Stinson, E.B., Billingham. M.E., Popp, R.L. Sensitivity and specificity of diastolic indexes for rejection surveillance: temporal correlation with endomyocardial biopsy. Journal of Heart and Lung Transplantation 1991; 10:757-765.
Tugulea et al., 1997, “New Stategies for Early Diagnosis of Heart Allograft Rejection,” Transplantation (Williams and Wilkins, Baltimore, MD, US) 64(6):842-
Baker & Botts LLP
Saunders David
LandOfFree
Method for predicting transplant rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for predicting transplant rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for predicting transplant rejection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3638929